MAMMOMAT RevelationWith 50⁰ Wide-Angle Tomosynthesis. Superior by design.
1
Compared to FFDM; Zackrisson S, Lång K, Rosso A, Johnson K, Dustler M, Förnvik D et al. (2018) One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): A prospective, population-based, diagnostic accuracy study. The Lancet Oncology. doi:10.1016/S1470-2045(18)30521-7.
2
Compared to FFDM; PMA P140011/S001 & P140011/S003; Georgian et al. (2019): Can Digital Breast Tomosynthesis Replace Full-Field Digital Mammography? A Multireader, Multicase Study of Wide-Angle Tomosynthesis. AJR 2019, pp. 1-7. doi.org/10.2214/AJR.18.20294
3
Maldera et al. (2016): Digital breast tomosynthesis: Dose and image quality assessment. Physica Medica, pp. 1-12.
4
Scaduto et al. (2018) Impact of angular range of digital breast tomosynthesis on mass detection in dense breasts," Proc. SPIE 10718, 14th International Workshop on Breast Imaging (IWBI 2018), 107181V (6 July 2018); doi: 10.1117/12.2318243
5
Data on file
6
Data on file
7
Talk of Prof. Van Ongeval at Breast Care Day 2019, Vienna: https://www.siemens-healthineers.com/mammography/informationgallery/videos
8
Compared to grid-based acquisition with MAMMOMAT Revelation, depending on breast thickness - L.B. Larsen, A. Fieselmann, H. Pfaff, T. Mertelmeier Performance of grid-less digital mammography acquisition technique for breast screening: analysis of 22,117 examinations Presentation B-1025 ECR 2015.
9
Data on file
Please note that the following features are options: 50° Wide-Angle Tomosynthesis with Insight 2D and 3D, 50° Wide-Angle Biopsy with InSpect, Insight BD, TiCEM, Personalized Soft Compression, and MoodLight
Maldera et al. (2016): Digital breast tomosynthesis: Dose and image quality assessment. Physica Medica, pp. 1-12.; Marshall N.W. and Bosmans H. (2012): Measurements of system sharpness for two digital breast tomosynthesis systems. Phys. Med. Biol. 57, pp. 7629-7650.; Rodríguez-Ruiz A. et al. (2016): Evaluation of the technical performance of three different commercial digital breast tomosynthesis systems in the clinical environment. Physica Medica 32, pp. 767-777.
2
Option
3
Uchiyama N. et al. (2016): Diagnostic Usefulness of Synthetic MMG (SMMG) with DBT (Digital Breast tomosynthesis) for Clinical – Setting in Breast Cancer Screening. Springer International Publishing Switzerland. IWDM 2016, LNCS 9699, pp. 59–67.
4
Lång K. et al. (2016): Performance of one-view breast tomosynthesis as a stand-alone breast cancer screening modality: results from the Malmö BreastTomosynthesis Screening Trial, a population-based study. Eur Radiol 26, pp. 184-190. (Please note: Final result will be presented at RSNA 2017)
5
“1-view tomo only” is not FDA approved in the U.S.
6
Compared to grid-based acquisition with Mammomat Inspiration, depending on breast thickness - L.B. Larsen, A. Fieselmann, H. Pfaff, T. Mertelmeier Performance of grid-less digital mammography acquisition technique for breast screening: analysis of 22,117 examinations Presentation B-1025 ECR 2015
MAMMOMAT Revelation is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
1
Option
The statements by Siemens Healthineers’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.
MAMMOMAT Revelation is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.